Orchiectomy or LHRH analogues in prostatic cancer?
Olsson, J.O.
Lakartidningen 87(4): 190
1990
ISSN/ISBN: 0023-7205 PMID: 2405226 Document Number: 366795
Document emailed within 1 workday
Related Documents
Knönagel, H.; Bolle, J.F.; Hering, F.; Senn, E.; Hodel, T.; Neuenschwander, H.; Biedermann, C. 1989: Therapy of metastatic prostatic cancer by orchiectomy plus Anandron versus orchiectomy plus placebo. Initial results of a randomized multicenter study Helvetica Chirurgica Acta 56(3): 343-345Debruyne, F.M.; Fernandez del Moral, P.; Geboers, A.D. 1988: LHRH-analogues therapy for metastatic prostate cancer Progress in Clinical and Biological Research 260: 27-39
Labrie, F.; Dupont, A.; Giguère, M.; Borsanyi, J.P.; Lacourciere, Y.; Bélanger, A.; Lachance, R.; Emond, J.; Monfette, G. 1988: Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer Progress in Clinical and Biological Research 260: 41-62
Debruyne, F.M.; Karthaus, H.F.; Schröder, F.H.; de Voogt, H.J.; de Jong, F.H.; Klijn, J.G. 1985: Results of a Dutch Phase Ii trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer Progress in Clinical and Biological Research 185a: 251-270
Rorth, M. 1985: Non-seminomatous testicular cancer stage I. Orchiectomy alone versus orchiectomy + radiotherapy: a randomized study by the Danish Testicular Cancer Study Group Progress in Clinical and Biological Research 203: 561
De Voogt, H.J.; Adenauer, H.; Widdra, W.G. 1991: The use of the LHRH-analogue Buserelin in the treatment of prostatic cancer. a 10-year review on 1522 patients treated in 119 centres on 4 continents Scandinavian Journal of Urology and Nephrology. Supplementum 138: 131-136
Sandow, J. 1983: Clinical applications of LHRH and its analogues Clinical Endocrinology 18(6): 571-592
Studer, U.E.; Münch, D. 1990: Hormonal therapy (medical orchiectomy) in prostatic carcinoma Schweizerische Medizinische Wochenschrift 120(24): 881-887
Keizman, D.; Eisenberger, M.A. 2009: LHRH antagonists vs LHRH agonists: which is more beneficial in prostate cancer therapy? Oncology 23(7): 631-632
Anderson, K.E. 1989: LHRH analogues for hormonal manipulation in acute intermittent porphyria Seminars in Hematology 26(1): 10-15
Korczak, D.; Golomb, J.; Siegel, Y.; Lindner, A. 1988: Treatment of advanced prostatic carcinoma with LHRH analogue Harefuah 115(5-6): 109-111
Dondi, D.; Limonta, P.; Moretti, R.M.; Marelli, M.M.; Garattini, E.; Motta, M. 1994: Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: evidence for an autocrine-inhibitory LHRH loop Cancer Research 54(15): 4091-4095
Van Poppel, H.; Werbrouck, P.W.; Baert, L. 1990: Effect of estramustine phosphate on free androgens. a comparative study of the effect of orchiectomy and estramustine phosphate on free androgens in patients with prostatic cancer Acta Urologica Belgica 58(4): 89-95
Bertelli, A. 1990: Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH Drugs under Experimental and Clinical Research 16(Suppl): 1-2
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700
Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Kuber, W.; Treu, T.; Kratzik, C.; Girsch, E.; Zeillinger, R.; Spona, J. 1990: Chemical castration using a depot LHRH-agonist as a palliative therapy concept in prostatic carcinoma--clinical, endocrinological and experimental studies Wiener Klinische Wochenschrift 102(21): 640-647
Becher, R.; Höffken, K.; Pape, H.; Schmidt, C.G. 1981: Tamoxifen treatment before orchiectomy in advanced breast cancer in men New England Journal of Medicine 305(3): 169-170
Fosså, S.D.; Abyholm, T.; Aakvaag, A. 1984: Spermatogenesis and hormonal status after orchiectomy for cancer and before supplementary treatment European Urology 10(3): 173-177
Arimura, A.; Talbot, S.; Serafini, P.C.; Schally, A.V. 1980: Sites of paradoxical action of the LHRH agonist (D-Trp6)-LHRH International Journal of Fertility 25(3): 151-156